UnicoCell Biomed Co., Ltd. (TPE:6794)
82.00
+1.00 (1.22%)
Mar 10, 2026, 12:38 PM CST
UnicoCell Biomed Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | -114.84 | -93.07 | -84.11 | -91.16 | -86.37 | Upgrade
|
| Depreciation & Amortization | 20.55 | 27.25 | 26.18 | 24.09 | 25.53 | Upgrade
|
| Other Amortization | - | 0.33 | 0.21 | 0.18 | 0.74 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -4.83 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.67 | 1.79 | - | - | - | Upgrade
|
| Stock-Based Compensation | 5.12 | 1.39 | 1.82 | 2.96 | 2.26 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.12 | 0 | 0 | - | - | Upgrade
|
| Other Operating Activities | 1.29 | -1.25 | -3.42 | -0.07 | 0.29 | Upgrade
|
| Change in Accounts Receivable | -0.51 | -0.73 | -0.7 | -0.98 | 0.36 | Upgrade
|
| Change in Inventory | -0.62 | -2.33 | 0.72 | -0.07 | -2.1 | Upgrade
|
| Change in Accounts Payable | -0.75 | 1.87 | -0.81 | 0.84 | -0.4 | Upgrade
|
| Change in Unearned Revenue | -5.52 | 6.6 | -1.51 | 1.52 | - | Upgrade
|
| Change in Other Net Operating Assets | 3.18 | -3.36 | 0.9 | -0.92 | -2.02 | Upgrade
|
| Operating Cash Flow | -91.31 | -61.52 | -65.55 | -63.6 | -61.71 | Upgrade
|
| Capital Expenditures | -5.5 | -5.32 | -15.8 | -14.45 | -23.64 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 6.16 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.23 | -0.38 | -0.18 | -0.16 | -0.36 | Upgrade
|
| Investment in Securities | -167.9 | -117.35 | -297.14 | -150.08 | -0.08 | Upgrade
|
| Other Investing Activities | 0.14 | 0.71 | -0.24 | -0.3 | 0.27 | Upgrade
|
| Investing Cash Flow | -173.49 | -122.35 | -307.2 | -164.99 | -23.8 | Upgrade
|
| Long-Term Debt Repaid | -6.22 | -6.09 | -6.04 | -7.82 | -9.37 | Upgrade
|
| Net Debt Issued (Repaid) | -6.22 | -6.09 | -6.04 | -7.82 | -9.37 | Upgrade
|
| Issuance of Common Stock | 302.29 | 179.85 | 344.88 | 159.04 | 3.71 | Upgrade
|
| Other Financing Activities | - | -0.22 | 0.17 | 0.15 | - | Upgrade
|
| Financing Cash Flow | 296.07 | 173.54 | 339.01 | 151.38 | -5.66 | Upgrade
|
| Net Cash Flow | 31.27 | -10.33 | -33.74 | -77.21 | -91.17 | Upgrade
|
| Free Cash Flow | -96.81 | -66.84 | -81.35 | -78.05 | -85.34 | Upgrade
|
| Free Cash Flow Margin | -321.59% | -209.66% | -330.82% | -542.15% | -1043.70% | Upgrade
|
| Free Cash Flow Per Share | -1.59 | -1.17 | -1.51 | -1.88 | -2.27 | Upgrade
|
| Cash Interest Paid | - | 1.46 | 1.45 | 1.26 | 0.66 | Upgrade
|
| Cash Income Tax Paid | - | 0.72 | 0.24 | 0.02 | 0.04 | Upgrade
|
| Levered Free Cash Flow | -67 | -44.47 | -54.17 | -49.26 | -54.15 | Upgrade
|
| Unlevered Free Cash Flow | -66.16 | -43.56 | -53.27 | -48.47 | -53.74 | Upgrade
|
| Change in Working Capital | -4.22 | 2.05 | -1.4 | 0.39 | -4.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.